Stay updated on CC-96191 in AML Clinical Trial

Sign up to get notified when there's something new on the CC-96191 in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-96191 in AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in medical or healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-06-06T14:28:35.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    9 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 23 to 30, indicating a recent update in medical or healthcare-related publications and documentation.
    Difference
    0.3%
    Check dated 2024-05-31T10:12:10.000Z thumbnail image
  7. Check
    16 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 2023-09-28 to 2024-05-23, indicating a recent change in the study details related to CC-96191 in participants with relapsed or refractory Acute Myeloid Leukemia, possibly reflecting new information or developments in the medical and healthcare-related publications and documentation.
    Difference
    1.0%
    Check dated 2024-05-24T03:28:15.000Z thumbnail image
  8. Check
    17 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating an update in the number of study record versions submitted. This change likely reflects the addition of a new version of a clinical study record related to medical and healthcare research.
    Difference
    0.3%
    Check dated 2024-05-22T20:58:40.000Z thumbnail image
  9. Check
    39 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:46:49.000Z thumbnail image

Stay in the know with updates to CC-96191 in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-96191 in AML Clinical Trial page.